YM BioSciences Inc.(Toronto Stock Exchange : YMI)
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Health Technology » Pharmaceuticals Major
YM BioSciences, Inc. is a drug development company advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada.